NCT00048620View on ClinicalTrials.gov

Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Study Completion Date

November 30, 2005

Conditions
Mucopolysaccharidosis VI
Interventions
DRUG

N-acetylgalactosamine 4-sulfatase

Trial Locations (1)

94949

BioMarin Pharmaceutical Inc., Novato

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY